USD 0.01
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2022 | -111.54 Thousand CAD | -464.73% |
2021 | 30.58 Thousand CAD | 281.27% |
2020 | 8021.00 CAD | 0.0% |
2019 | - CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
2014 | - CAD | 0.0% |
2013 | - CAD | 0.0% |
2012 | - CAD | 0.0% |
2011 | - CAD | 0.0% |
2010 | - CAD | 0.0% |
2009 | - CAD | 0.0% |
2008 | - CAD | 0.0% |
2007 | - CAD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 Q2 | - CAD | 0.0% |
2023 Q1 | - CAD | 100.0% |
2023 Q3 | - CAD | 0.0% |
2022 Q2 | 1803.00 CAD | -48.35% |
2022 Q1 | 3491.00 CAD | -60.45% |
2022 FY | -111.54 Thousand CAD | -464.73% |
2022 Q4 | -120.67 Thousand CAD | -3245.78% |
2022 Q3 | 3836.00 CAD | 112.76% |
2021 Q3 | 12.37 Thousand CAD | 89.67% |
2021 Q4 | 8827.00 CAD | -28.65% |
2021 FY | 30.58 Thousand CAD | 281.27% |
2021 Q1 | 2860.00 CAD | -82.17% |
2021 Q2 | 6523.00 CAD | 128.08% |
2020 FY | 8021.00 CAD | 0.0% |
2020 Q1 | - CAD | 100.0% |
2020 Q2 | - CAD | 0.0% |
2020 Q3 | - CAD | 0.0% |
2020 Q4 | 16.04 Thousand CAD | 0.0% |
2019 Q2 | 90.63 Thousand CAD | -68.26% |
2019 Q1 | 285.51 Thousand CAD | 0.0% |
2019 FY | - CAD | 0.0% |
2019 Q3 | 27.3 Thousand CAD | -69.87% |
2019 Q4 | -558.94 Thousand CAD | -2147.11% |
2018 Q3 | 900.39 Thousand CAD | 18.65% |
2018 FY | - CAD | 0.0% |
2018 Q1 | 1.02 Million CAD | 0.0% |
2018 Q4 | - CAD | -100.0% |
2018 Q2 | 758.87 Thousand CAD | -26.09% |
2017 Q4 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2016 Q1 | - CAD | 0.0% |
2016 Q4 | - CAD | 0.0% |
2015 Q1 | - CAD | 0.0% |
2015 FY | - CAD | 0.0% |
2015 Q4 | - CAD | 0.0% |
2015 Q3 | - CAD | 0.0% |
2015 Q2 | - CAD | 0.0% |
2014 Q4 | - CAD | 0.0% |
2014 FY | - CAD | 0.0% |
2014 Q1 | - CAD | 0.0% |
2014 Q3 | - CAD | 0.0% |
2014 Q2 | - CAD | 0.0% |
2013 Q1 | - CAD | 0.0% |
2013 FY | - CAD | 0.0% |
2013 Q4 | - CAD | 0.0% |
2013 Q3 | - CAD | 0.0% |
2013 Q2 | - CAD | 0.0% |
2012 Q2 | - CAD | 0.0% |
2012 Q1 | - CAD | 0.0% |
2012 Q3 | - CAD | 0.0% |
2012 Q4 | - CAD | 0.0% |
2012 FY | - CAD | 0.0% |
2011 FY | - CAD | 0.0% |
2011 Q1 | - CAD | 0.0% |
2011 Q4 | - CAD | 0.0% |
2011 Q2 | - CAD | 0.0% |
2011 Q3 | - CAD | 0.0% |
2010 Q4 | - CAD | 0.0% |
2010 Q3 | - CAD | 0.0% |
2010 Q2 | - CAD | 0.0% |
2010 Q1 | - CAD | 0.0% |
2010 FY | - CAD | 0.0% |
2009 Q1 | - CAD | 0.0% |
2009 Q4 | - CAD | 0.0% |
2009 Q3 | - CAD | 0.0% |
2009 Q2 | - CAD | 0.0% |
2009 FY | - CAD | 0.0% |
2008 Q3 | - CAD | 0.0% |
2008 Q1 | - CAD | 0.0% |
2008 FY | - CAD | 0.0% |
2008 Q4 | - CAD | 0.0% |
2008 Q2 | - CAD | 0.0% |
2007 Q3 | - CAD | 0.0% |
2007 FY | - CAD | 0.0% |
2007 Q4 | - CAD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
China Medicine Corporation | 18.98 Million USD | 100.588% |
DH Enchantment Inc. | -406.00 USD | -27373.399% |
Exlites Holdings International, Inc. | 18.74 Thousand USD | 695.208% |
Itonis, Inc. | 1801.00 USD | 6293.337% |
One Step Vending Corp. | -1238.00 USD | -8909.855% |
MediPal Holdings Corporation | 1.53 Billion USD | 100.007% |
PD-Rx Pharmaceuticals, Inc. | 6.71 Million USD | 101.662% |
Pharmagen, Inc. | 3045.21 USD | 3762.867% |
Suzuken Co., Ltd. | 1.22 Billion USD | 100.009% |